Literature DB >> 10840989

Asymptomatic bacteriuria may be considered a complication in women with diabetes. Diabetes Mellitus Women Asymptomatic Bacteriuria Utrecht Study Group.

S E Geerlings1, R P Stolk, M J Camps, P M Netten, J B Hoekstra, K P Bouter, B Bravenboer, J T Collet, A R Jansz, A I Hoepelman.   

Abstract

OBJECTIVE: To study the prevalence of and risk factors for asymptomatic bacteriuria (ASB) in women with and without diabetes. RESEARCH DESIGN AND METHODS: A total of 636 nonpregnant women with diabetes (type 1 and type 2) who were 18-75 years of age and had no abnormalities of the urinary tract, and 153 women without diabetes who were visiting the eye and trauma outpatient clinic (control subjects) were included. We defined ASB as the presence of at least 10(5) colony-forming units/ml of 1 or 2 bacterial species in a culture of clean-voided midstream urine from an individual without symptoms of a urinary tract infection (UTI).
RESULTS: The prevalence of ASB was 26% in the diabetic women and 6% in the control subjects (P < 0.001). The prevalence of ASB in women with type 1 diabetes was 21%. Risk factors for ASB in type 1 diabetic women included a longer duration of diabetes, peripheral neuropathy, and macroalbuminuria. The prevalence of ASB was 29% in women with type 2 diabetes. Risk factors for ASB in type 2 diabetic women included age, macroalbuminuria, a lower BMI, and a UTI during the previous year. No association was evident between current HbA1c level and the presence of ASB.
CONCLUSIONS: The prevalence of ASB is increased in women with diabetes and might be added to the list of diabetic complications in these women.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10840989     DOI: 10.2337/diacare.23.6.744

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  43 in total

Review 1.  [Gynaecological and obstetrical aspects of recurrent urinary tract infections].

Authors:  U B Hoyme; P Schneede
Journal:  Urologe A       Date:  2006-04       Impact factor: 0.639

2.  Prediction of complicated urinary tract infections in patients with type 2 diabetes: a questionnaire study in primary care.

Authors:  Leonie M A J Venmans; Marian Sloof; Eelko Hak; Kees J Gorter; Guy E H M Rutten
Journal:  Eur J Epidemiol       Date:  2007-01-03       Impact factor: 8.082

Review 3.  [Symptomatic urinary tract infection of the female--diagnostics].

Authors:  T Bruns; H Piechota; P Schneede
Journal:  Urologe A       Date:  2006-04       Impact factor: 0.639

4.  Can studies of harm be harmful?

Authors:  Joel G Ray
Journal:  CMAJ       Date:  2008-12-02       Impact factor: 8.262

5.  Risk factors for urinary incontinence among women with type 1 diabetes: findings from the epidemiology of diabetes interventions and complications study.

Authors:  Aruna V Sarma; Alka Kanaya; Leroy M Nyberg; John W Kusek; Eric Vittinghoff; Brandy Rutledge; Patricia A Cleary; Patricia Gatcomb; Jeanette S Brown
Journal:  Urology       Date:  2009-04-10       Impact factor: 2.649

Review 6.  Renal glucose transporters: novel targets for hyperglycemia management.

Authors:  Amanda Mather; Carol Pollock
Journal:  Nat Rev Nephrol       Date:  2010-03-30       Impact factor: 28.314

7.  Clinical profile of urinary tract infections in diabetics and non-diabetics.

Authors:  Srinivas M Aswani; Uk Chandrashekar; Kn Shivashankara; Bc Pruthvi
Journal:  Australas Med J       Date:  2014-01-31

8.  Prevalence and risk factors for bothersome lower urinary tract symptoms in women with diabetes mellitus from hospital-based diabetes clinic.

Authors:  Abdalla M Fayyad; Simon R Hill; Geraint Jones
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-07-15

9.  Diabetes Mellitus has no Significant Influence on the Prevalence of Antenatal Asymptomatic Bacteriuria.

Authors:  Nissi Priya Mekapogu; Swarnalatha Gundela; Renuka Devi Avula
Journal:  J Clin Diagn Res       Date:  2016-04-01

10.  Clinical factors associated with shock in bacteremic UTI.

Authors:  Katsumi Shigemura; Kazushi Tanaka; Kayo Osawa; Sochi Arakawa; Hideaki Miyake; Masato Fujisawa
Journal:  Int Urol Nephrol       Date:  2013-04-25       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.